Dr. Veldman is a full-time member of the Cornea and Refractive Surgery Service at Mass. Eye and Ear with specialized expertise in lamellar or partial thickness corneal transplantation including Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Deep Anterior Lamellar Keratoplasty (DALK), and Penetrating Keratoplasty (PK). In addition to practicing at Mass. Eye and Ear's main Boston campus and Longwood locations, Dr. Veldman sees patients at the hospital's One Montvale Avenue, Stoneham office location.
Dr. Veldman obtained his MD from the Perelman School of Medicine at the University of Pennsylvania, where he received the Jeffrey W. Berger Research in Ophthalmology Award and the Charles A. Oliver Memorial Prize, recognizing the highest academic performance of Penn medical students entering Ophthalmology. He then completed his ophthalmology residency at Harvard Medical School and served as Chief Resident and Director of the Ocular Trauma Service at Mass. Eye and Ear for the 2012-2013 academic year. Subsequently, he pursued specialized training in the lamellar (partial thickness) corneal procedures-including DMEK, the thinnest corneal transplant available -as a Cornea Fellow at Devers Eye Institute in Portland, Oregon under the direction of Drs. Mark Terry and Michael Straiko. As a result of this training, Dr. Veldman is able to offer corneal transplantation options that specifically treat his patients' diseases without sacrificing otherwise healthy corneal tissues. This approach offers a number of advantages, including faster and better visual recovery as well as decreased risk of graft rejection.
As a clinician scientist, Dr. Veldman has contributed to a number of important research initiatives and publications. In particular, he published a review of the evolving role of DSAEK following the emergence of DMEK as the procedure of choice in endothelial keratoplasty. His research during fellowship focused on the introduction of, and outcomes using, a stromal sided S-stamp in DMEK, which has to date eliminated upside down DMEK graft implantation, a primary cause of graft failure in DMEK. This work was completed in both laboratory and clinical settings through close collaboration with Lions VisionGift, an eye bank located in Portland, OR.
Corneal Surgery, Corneal Transplantation, Lamellar or Partial Thickness Corneal Procedures including: DSAEK, DALK and DMEK, Cataract, Complex Cataract, International Ophthalmology
Ocular Trauma, Endothelial Keratoplasty (DMEK and DSAEK)
For a full publication list, please see his CV.
Treatment of Fuchs Endothelial Dystrophy by Descemet Stripping without Endothelial Keratoplasty. Borkar DS, Veldman PB, Colby KA. Cornea. 2016 Jun 15. (Epub ahead of print)
Endothelial Keratoplasty: Descemet's Stripping Automated Endothelial Keratoplasty vs Descemet Membrane Endothelial Keratoplasty. Yin J, Veldman PB. International Ophthalmology Clinics. 2016 Summer; 56(3): 167-83.
Evidence Based Endothelial Keratoplasty. Liu S, Veldman PB. Seminars in Ophthalmology 2016 (In press)
Evidence Based Post-Operative Management in Descemet Membrane Endothelial Keratoplasty. Rappaport Y, Veldman PB. Seminars in Ophthalmology 2016 (In press)
Evolving indications for Descemet's stripping automated endothelial keratoplasty. Veldman P, Terry M, Straiko M.Curr Opin Ophthalmol. 2014 May 30.
Cosmetic Iris Implants: Two Cases of Explantation Secondary to Uveitis, Glaucoma and Corneal Decompensation. Veldman P, Behlou I, Soriano E, Starling JC, Pineda R. Archives of Ophthalmology. 2012;130(6):787-789. (Cover Photo)
Current Evidence for Topical Azithromycin 1% Ophthalmic Solution in the Treatment of Blepharitis and Blepharitis Associated Ocular Dryness.Veldman P, Colby K.International Ophthalmology Clinics. 2011;51(4): 43-52.
View a complete list of publications on pubmed.gov>>
To learn more about Dr. Veldman, read his "Meet a Specialist" profile here.